These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18401160)

  • 1. Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches.
    Thongboonkerd V
    Contrib Nephrol; 2008; 160():37-52. PubMed ID: 18401160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of diabetic nephropathy in the proteomic era.
    Thongboonkerd V
    Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel biomarkers for diabetic nephropathy].
    Araki S
    Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
    Conserva F; Pontrelli P; Accetturo M; Gesualdo L
    J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent technological developments in proteomics shed new light on translational research on diabetic microangiopathy.
    Ma Y; Yang C; Tao Y; Zhou H; Wang Y
    FEBS J; 2013 Nov; 280(22):5668-81. PubMed ID: 23763694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.
    Papadopoulou-Marketou N; Chrousos GP; Kanaka-Gantenbein C
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27457509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?
    Papale M; Di Paolo S; Vocino G; Rocchetti MT; Gesualdo L
    J Nephrol; 2014 Jun; 27(3):221-8. PubMed ID: 24567069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics and diabetic nephropathy.
    Merchant ML; Klein JB
    Curr Diab Rep; 2005 Dec; 5(6):464-9. PubMed ID: 16316599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria: a parameter that has changed diabetes care.
    Parving HH; Persson F; Rossing P
    Diabetes Res Clin Pract; 2015 Jan; 107(1):1-8. PubMed ID: 25467616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.
    Lindhardt M; Persson F; Currie G; Pontillo C; Beige J; Delles C; von der Leyen H; Mischak H; Navis G; Noutsou M; Ortiz A; Ruggenenti PL; Rychlik I; Spasovski G; Rossing P
    BMJ Open; 2016 Mar; 6(3):e010310. PubMed ID: 26936907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics and systems biology for understanding diabetic nephropathy.
    Starkey JM; Tilton RG
    J Cardiovasc Transl Res; 2012 Aug; 5(4):479-90. PubMed ID: 22581264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New molecular insights in diabetic nephropathy.
    Checheriţă IA; Manda G; Hinescu ME; Peride I; Niculae A; Bîlha Ş; Grămăticu A; Voroneanu L; Covic A
    Int Urol Nephrol; 2016 Mar; 48(3):373-87. PubMed ID: 26759327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics and diabetic nephropathy.
    Merchant ML; Klein JB
    Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible role of glutathione-S-transferase activity in diabetic nephropathy.
    Tesauro M; Nisticò S; Noce A; Tarantino A; Marrone G; Costa A; Rovella V; Di Cola G; Campia U; Lauro D; Cardillo C; Di Daniele N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):129-33. PubMed ID: 25816416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in the management of diabetic nephropathy.
    Waanders F; Visser FW; Gans RO
    Neth J Med; 2013 Nov; 71(9):448-58. PubMed ID: 24218418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of kidney and protective effects of grape seed procyanidin B2 in db/db mice indicate MFG-E8 as a key molecule in the development of diabetic nephropathy.
    Zhang Z; Li BY; Li XL; Cheng M; Yu F; Lu WD; Cai Q; Wang JF; Zhou RH; Gao HQ; Shen L
    Biochim Biophys Acta; 2013 Jun; 1832(6):805-16. PubMed ID: 23474305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokines in diabetic nephropathy.
    Donate-Correa J; Martín-Núñez E; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
    J Diabetes Res; 2015; 2015():948417. PubMed ID: 25785280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.
    Currie G; Delles C
    Curr Diab Rep; 2016 Nov; 16(11):104. PubMed ID: 27658932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.